Patrice Talaga

1.2k total citations
26 papers, 924 citations indexed

About

Patrice Talaga is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Immunology. According to data from OpenAlex, Patrice Talaga has authored 26 papers receiving a total of 924 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 5 papers in Immunology. Recurrent topics in Patrice Talaga's work include Receptor Mechanisms and Signaling (9 papers), Mast cells and histamine (5 papers) and Neuropeptides and Animal Physiology (5 papers). Patrice Talaga is often cited by papers focused on Receptor Mechanisms and Signaling (9 papers), Mast cells and histamine (5 papers) and Neuropeptides and Animal Physiology (5 papers). Patrice Talaga collaborates with scholars based in Belgium, France and Netherlands. Patrice Talaga's co-authors include Michel Gillard, Henrik Klitgaard, Rob Leurs, Sylvain Célanire, Alain Matagne, Maikel Wijtmans, Iwan J. P. de Esch, Philippe Michel, Benoît Kenda and Patrick Pasau and has published in prestigious journals such as Journal of Medicinal Chemistry, Tetrahedron and Biochemical Pharmacology.

In The Last Decade

Patrice Talaga

26 papers receiving 884 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrice Talaga Belgium 14 405 267 216 211 167 26 924
David J. Wustrow United States 20 746 1.8× 491 1.8× 611 2.8× 101 0.5× 54 0.3× 54 1.7k
Tjeerd Barf Netherlands 19 724 1.8× 267 1.0× 360 1.7× 55 0.3× 13 0.1× 33 1.7k
Kyung Soon Kim South Korea 16 418 1.0× 42 0.2× 170 0.8× 35 0.2× 26 0.2× 36 1.0k
Gary G. Chicchi United States 29 1.5k 3.7× 784 2.9× 473 2.2× 59 0.3× 28 0.2× 65 2.5k
Mirko Rivara Italy 19 437 1.1× 96 0.4× 231 1.1× 37 0.2× 16 0.1× 35 708
Wuyan Chen China 26 1.1k 2.7× 81 0.3× 99 0.5× 31 0.1× 34 0.2× 42 1.5k
Stefan Pype Belgium 13 395 1.0× 165 0.6× 46 0.2× 43 0.2× 12 0.1× 19 623
Timothy Harrison United Kingdom 25 1.1k 2.6× 611 2.3× 406 1.9× 57 0.3× 9 0.1× 52 1.7k
Stephen R. Fletcher United States 20 941 2.3× 323 1.2× 640 3.0× 54 0.3× 11 0.1× 38 1.8k
Henri Mattes Switzerland 17 507 1.3× 143 0.5× 247 1.1× 23 0.1× 7 0.0× 29 915

Countries citing papers authored by Patrice Talaga

Since Specialization
Citations

This map shows the geographic impact of Patrice Talaga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrice Talaga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrice Talaga more than expected).

Fields of papers citing papers by Patrice Talaga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrice Talaga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrice Talaga. The network helps show where Patrice Talaga may publish in the future.

Co-authorship network of co-authors of Patrice Talaga

This figure shows the co-authorship network connecting the top 25 collaborators of Patrice Talaga. A scholar is included among the top collaborators of Patrice Talaga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrice Talaga. Patrice Talaga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mortier, Jérémie, Raphaël Frédérick, Caroline Remouchamps, et al.. (2010). Pyrazolo[4,3-c]isoquinolines as potential inhibitors of NF-κB activation. Biochemical Pharmacology. 79(10). 1462–1472. 21 indexed citations
2.
Talaga, Patrice. (2010). Opinion: The Future of Pharmaceutical R&D: Somewhere Between Open and Reverse Innovation?. Future Medicinal Chemistry. 2(9). 1399–1403. 17 indexed citations
3.
Wijtmans, Maikel, Sylvain Célanire, Erwin Snip, et al.. (2008). 4-Benzyl-1H-imidazoles with Oxazoline Termini as Histamine H3Receptor Agonists. Journal of Medicinal Chemistry. 51(10). 2944–2953. 20 indexed citations
4.
Provins, Laurent, B. Christophe, Michel Gillard, et al.. (2008). Alkyne–quinuclidine derivatives as potent and selective muscarinic antagonists for the treatment of COPD. Bioorganic & Medicinal Chemistry Letters. 18(8). 2675–2678. 6 indexed citations
5.
Kamiński, Rafał M., Alain Matagne, Karine Leclercq, et al.. (2007). SV2A protein is a broad-spectrum anticonvulsant target: Functional correlation between protein binding and seizure protection in models of both partial and generalized epilepsy. Neuropharmacology. 54(4). 715–720. 137 indexed citations
6.
Fuks, B. B., et al.. (2005). In vitro properties of 5-(benzylsulfonyl)-4-bromo-2-methyl-3(2H)-pyridazinone: A novel permeability transition pore inhibitor. European Journal of Pharmacology. 519(1-2). 24–30. 15 indexed citations
7.
Célanire, Sylvain, Maikel Wijtmans, Patrice Talaga, Rob Leurs, & Iwan J. P. de Esch. (2005). Keynote review: Histamine H3 receptor antagonists reach out for the clinic. Drug Discovery Today. 10(23-24). 1613–1627. 165 indexed citations
8.
Talaga, Patrice, Luc Quéré, Philippe Collart, et al.. (2005). Potent anti-muscarinic activity in a novel series of quinuclidine derivatives. Bioorganic & Medicinal Chemistry Letters. 16(2). 373–377. 9 indexed citations
9.
Scannell, Ralph T., Edmond Differding, & Patrice Talaga. (2004). Dual Acting Antihistaminergic Agents. Mini-Reviews in Medicinal Chemistry. 4(9). 923–933. 9 indexed citations
10.
Talaga, Patrice. (2004). Inhibitors of beta-amyloid aggregation: still an issue of structure and function?. Drug Discovery Today Therapeutic Strategies. 1(1). 7–12. 4 indexed citations
11.
Ryckmans, Thomas, Olivier Berton, R. Grimée, et al.. (2003). Dual NK1 Antagonists—Serotonin Reuptake Inhibitors as Potential Antidepressants. Part 2. SAR and Activity of Benzyloxyphenethyl Piperazine Derivatives.. ChemInform. 34(8). 1 indexed citations
12.
Kenda, Benoît, Alain Matagne, Patrice Talaga, et al.. (2003). Discovery of 4-Substituted Pyrrolidone Butanamides as New Agents with Significant Antiepileptic Activity. Journal of Medicinal Chemistry. 47(3). 530–549. 202 indexed citations
13.
Diouf, Oumar, Michel Gelbcke, Patrice Talaga, et al.. (2002). A new series of M3 muscarinic antagonists based on the 4-amino-piperidine scaffold. Bioorganic & Medicinal Chemistry Letters. 12(18). 2535–2539. 8 indexed citations
14.
Ryckmans, Thomas, Olivier Berton, R. Grimée, et al.. (2002). Dual NK1 antagonists—serotonin reuptake inhibitors as potential antidepressants. Part 2: SAR and activity of benzyloxyphenethyl piperazine derivatives. Bioorganic & Medicinal Chemistry Letters. 12(21). 3195–3198. 28 indexed citations
15.
Ryckmans, Thomas, Olivier Berton, Christophe Génicot, et al.. (2002). First dual NK1 antagonists–serotonin reuptake inhibitors: synthesis and SAR of a new class of potential antidepressants. Bioorganic & Medicinal Chemistry Letters. 12(2). 261–264. 52 indexed citations
16.
Bocquet, Arnaud, et al.. (2001). Failure of GPI compounds to display neurotrophic activity in vitro and in vivo. European Journal of Pharmacology. 415(2-3). 173–180. 22 indexed citations
17.
Talaga, Patrice, Alain Matagne, & Henrik Klitgaard. (2001). Pharmacological evaluation of a diarylmethylene-piperidine derivative: a new potent atypical antipsychotic?. Bioorganic & Medicinal Chemistry Letters. 11(10). 1313–1316. 7 indexed citations
18.
Talaga, Patrice. (2001). beta-Amyloid Aggregation Inhibitors for the Treatment of Alzheimer Disease Dream or Reality?. Mini-Reviews in Medicinal Chemistry. 1(2). 175–186. 40 indexed citations
19.
20.
Talaga, Patrice, et al.. (1990). A New Synthesis of γ-Substituted α-Methylene-γ-butyrolactones (2-Methylene-4-alkanolides) using Catalysis by SnCI2/Amberlyst 15. Synthesis. 1990(6). 530–530. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David J. Wustrow Breakdown of academic impact, for papers by Tjeerd Barf Breakdown of academic impact, for papers by Kyung Soon Kim Breakdown of academic impact, for papers by Gary G. Chicchi Breakdown of academic impact, for papers by Mirko Rivara Breakdown of academic impact, for papers by Wuyan Chen Breakdown of academic impact, for papers by Stefan Pype Breakdown of academic impact, for papers by Timothy Harrison Breakdown of academic impact, for papers by Stephen R. Fletcher Breakdown of academic impact, for papers by Henri Mattes
Rankless by CCL
2026